Laura Lovett

Fitbit's CEO James Park told CNBC that the company will be submitting its technology to the FDA soon. 

The new tech is designed to help curb face-to-face interactions during the coronavirus pandemic. 

The Philadelphia-based startup was designed to help patients with organizing their prescription medications and via online support. 

Eko's ECG low ejection fraction tool will now be able to help clinicians spot cardiac complications associated with the novel coronavirus. 

A new study published by JMIR found that on average participants using Hinge Health's platform reported 68.5% improvement in pain. 

The company also published new research on its biofeedback tool. 

The companies will join forces and create a new app called My Next Health, which helps gauge risk for certain conditions, including the coronavirus. 

The new funding is expected to help the company grow its product line. 

At HIMSS20 Digital, Eugene Kogan, chief technical officer of the Center for Healthcare Informatics and Analytics in St. Petersburg, Russia, talks hurdles and wins of moving toward continuous care. 

WHO also released guidelines about contact tracing for the coronavirus yesterday.